Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcriptionAilin Bai, Hui Hu, Mandy Yeung, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2004
Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptorsQing Ge, Ailin Bai, Brendan Jones, et al.Cellular & Molecular Immunology|June 14, 2011
Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independentMobolaji O Olurinde, Ching-Hung Shen, Adam Drake, et al.Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP miceAilin Bai, Eileen Higham, Herman N Eisen, et al.Trends in Immunology|April 17, 2003
CD4+ T-cell responses to self-peptide--MHCQing Ge, Ailin Bai, Ching-Hung Shen, et al.The EMBO Journal|January 15, 2005
Tyrosine phosphatase SHP-2 is a mediator of activity-dependent neuronal excitotoxicityGabriel Rusanescu, Wentian Yang, Ailin Bai, et al.Proceedings of the National Academy of Sciences of the United States of America|June 3, 2004
Inhibition of influenza virus production in virus-infected mice by RNA interferenceQing Ge, Lily Filip, Ailin Bai, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cellsS Peter Bak, Mike Stein Barnkob, Ailin Bai, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2009
The impact of TCR-binding properties and antigen presentation format on T cell responsivenessAdam S Chervin, Jennifer D Stone, Phillip D Holler, et al.Cancer Research|August 17, 2010
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signalingAilin Bai, Kristan Meetze, Nhi Y Vo, et al.Pageof 2